Board of Directors
Sanjeev Luther (Chairman), Expert in the pharmaceutical industry working in business development and operations, currently Chief Executive Officer of Rafael Pharmaceuticals., a company operating under Rafael Holdings.
Alberto Gabizon, Co-founder of LipoMedix, renowned Professor of Medical Oncology at Shaare Zedek Medical Center and the Hebrew University of Jerusalem, expert in all aspects of liposome technology related to drug development, and co-inventor of Doxil®, a powerful and successful liposomal anticancer drug.
Praveen Tyle, Dr. Tyle is currently the Executive Vice President of Research and Development at Lexicon Pharmaceuticals. He joined Lexicon in May 2016 with more than 30 years of pharmaceutical industry experience of advancing new medical device and drug candidate pipelines to commercial success. He led and completed the successful merger of Vertical Pharmaceuticals and Trigen Laboratories with Osmotica Holdings in February 2016 where he served as the member of the board of directors, CEO & President from January 2013. Prior to his service at Osmotica, Dr. Tyle held a series of leadership positions within the pharmaceutical industry, including EVP and CSO for the United States Pharmacopeia, senior vice president and global head of R&D and BD&L at Novartis OTC, corporate senior vice president of global R&D and CSO at Bausch & Lomb. He serves as a member of the Board of Directors for Eyegate Pharmaceuticals, Inc., Waltham, MA and Orient Europharma Ltd., Taipei, Taiwan.
Miranda J. Toledano, serves as Chief Operating Officer and Chief Financial Officer at TRIGR Therapeutics. From September 2016 until August 2017, served on the executive management team of Sorrento Therapeutics as EVP Corporate Development. From 2012 to 2016, served as Head of Healthcare Investment Banking at MLV & Co. Prior to joining MLV, from 2004 until 2010, she served in the investment group of Royalty Pharma, a leading investment firm with over $15 billion in biotherapeutic royalty assets. Ms. Toledano holds a BA in Economics from Tufts University and an MBA in Finance and Entrepreneurship from the NYU Stern School of Business.
Jacob Serfati, Representing Kepler Holdings, expert investor, in the Latin-American pharmaceutical industry and founder of Jayor Pharmaceutical Co., from Miami, FL.
Rami Kremien, Co-founder of Lipomedix, business investor with 35 years of experience in banking industry and in finance & business management.